Independent Medical Education Request for Proposals - KRAS G12C+ NSCLC
Genentech's grant supports independent medical education projects that advance knowledge and care in KRAS G12C+ non-small cell lung cancer.
Funder: Genentech
Due Dates: September 16, 2026: Full application deadline
Funding Amounts: Up to $225,000 per award; typically for single-year educational projects.
Summary: Supports independent medical education projects addressing knowledge gaps and advancing care in KRAS G12C+ non-small cell lung cancer.
Description
This opportunity supports independent, accredited medical education projects focused on KRAS G12C+ non-small cell lung cancer (NSCLC). Genentech seeks proposals that address current gaps in knowledge and clinical practice, aiming to improve outcomes for patients with this genomically distinct NSCLC subtype. The initiative is designed for U.S.-based educational providers to develop creative, evidence-based programs targeting community oncologists and multidisciplinary cancer care teams. Projects should address the rapidly evolving treatment landscape, including new targeted therapies and best practices for integrating genomic advances into care.
